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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S369Figure 2. (a) Plot of cartilage thickness and trabecular thickness, wherein
each sample speciﬁc correlation yields an inverse relationship in sclerotic
samples. Individual correlation coefﬁcients are R ¼ 0.62, 0.87, 0.88, 0.85.
0.60, 0.77, respectively, (b) Plot of denuded surface and bone volume/total
volume, indicating, for each sample, greater bone density in regions of lost
cartilage coverage. Individual correlation coefﬁcients are R ¼ 0.41, 0.84,
0.74, 0.38, 0.80, 0.41, respectively. The combined correlation coefﬁcients
for Cg.Th versus Tb.Th and %DS versus BV/TV, are 0.74 and 0.56, respec-
tively.
Conclusions: The results of this work show different relationships
between cartilage and bone structures in end stage OA samples dis-
playing bone sclerosis, than for samples with a more osteoporosis-like
change. This suggests that identifying the structural cues involved with
OA disease progression could allow for a more accurate diagnosis of
disease. It must be stated, however, that more osteoporotic-like samples
will need to be measured to conﬁrm this result. Speciﬁcally, changes
associated with sclerotic or osteoporotic-like bone change may require
alternative physical therapy or drug regimes. Future work will focus on
correlating these structural changes to speciﬁc genes and signalling
pathways, as well as biomechanical loading and use patterns in the
shoulder joint.
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NKX3.2-BARX1 CROSSTALK IN CHONDROCYTE AND ITS ROLE IN
OSTEOARTHRITIS PATHOGENESIS
D-W. Kim. Yonsei Univ., Seoul, REPUBLIC OF KOREA
Osteoarthritis (OA) is a prevalent disease affecting majority of aged
human, yet its effective treatment is currently absent. We have pre-
viously shown that Nkx3.2-mediated consitutive activation of NF-kB
functions to maintain chondrocyte viability. Besides, Barx1 has been
implicated for its role in development of gut, spleen and craniofacial
skeletons, but its precise molecular function in chondrocyte has been
poorly understood. Here we show that Barx1 can induce programmed
cell death in chondrocyte by abrogating Nkx3.2-mediated NF-kB acti-
vation. Interestingly, we also observed remarkable decrease and
increase in Nkx3.2 and Barx1 expression, respectively, both in mouse
OA models and in human OA patients. Consistent with these, in vivo
experiments employing intra-articular infection of Lentivirusmodifying Nkx3.2 or Barx1 expression revealed that osteoarthritic
cartilage destruction can be suppressed by Nkx3.2, whereas Barx1
aggravates it. Furthermore, importantly, we observed that either Nkx3.2
overexpression or Barx1 knockdown is capable of rendering regener-
ation of damaged cartilage in DMM-OA analyses in mice. Lastly, we
demonstrate that OA progression is decelerated and accelerated in
Nkx3.2 transgenic and knockout mice, respectively. Thus, these results
indicate that Nkx3.2-Barx1 crosstalk plays a role in OA pathogenesis
and may serve as promising therapeutic targets for OA modiﬁcation.
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INVESTIGATION ON THE ROLE OF DELTA/NOTCH LIKE EGF-RELATED
RECEPTOR IN THE PATHOGENESIS OF OSTEOARTHRITIS
L. Berninger y, A. Balkenhol y, C. Baier z, U. M€uller-Ladner y,
E. Neumann y, M. Geyer y. y Justus-Liebig-Univ. of Giessen, Kerckhoff-
Klinik, Bad Nauheim, Germany; zUniv. of Regensburg, Regensburg,
Germany
Purpose: Delta/Notch like EGF-related receptor (DNER) is a single-pass
transmembrane protein with characteristic EGF-like repeats in the
extracellular domain, similar to those of the Notch receptor and its
ligand Delta. In our previous study, an overexpression of DNER mRNA
was observed in lesional areas of human osteoarthritis (OA) articular
cartilage compared to unaffected zones of the same tissue sample.
Based on these ﬁndings and on the fact that the Notch signaling path-
way plays a major role in cell fate regulation and differentiation of
human articular chondrocytes, we analyzed the role of DNER in the
pathogenesis of OA.
Methods: Articular cartilagewas obtained fromOA patients undergoing
joint replacement surgery. The expression of DNER in human cartilage
was analyzed by immunohistochemistry. Normal human articular
chondrocytes (HNAC-kn) purchased from Lonza, Walkersville, MD, USA
were nucleofected with an overexpression vector targeting DNER and a
vector control. Overexpression of DNER was conﬁrmed by immunocy-
tochemical staining. For determining the effect of DNER overexpression
on speciﬁc cartilage metabolic parameters gene chip technology
(Affymetrix) and semi-quantitative real-time PCR was used.
Results: Histologically, DNER was signiﬁcantly increased in the affected
cartilage of all patients (n¼ 3) compared to the intact zones of the same
tissue. After nucleofection an upregulation of DNER in normal human
chondrocytes was detectable on protein level. Gene chip technology
showed that DNER overexpression caused an upregulation of the Spen
family transcriptional repressor (1.86 fold) and a downregulation of
Bone marrow stromal cell antigen 2 (-2.2 fold) and Tripartite motif
containing 22 (-2.07 fold). No changes were detectable on speciﬁc car-
tilage metabolic parameters like Collagen type 2, Sox9, MMP13,
ADAMTS4 and ADAMTS5, as well as on differentiation markers like
Collagen type 1 and a target gene of the Notch signaling pathway, HES-1.
Conclusion: Reorganization and reassembly of cartilage extracellular
matrix through downstream effects of DNER overexpression might be
enhanced by chondrocyte hypertrophy via upregulation of Spen family
transcriptional repressor, whilst downregulation of the integrin-
induced proteins Bone marrow stromal cell antigen 2 and Tripartite
motif containing 22 may inﬂuence programmed apoptosis and pro-
liferation, eventually via intermediate inﬂammatory stages.
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BONE CHANGES PRECEED CARTILAGE DEGRADATION IN
EXPERIMENTAL OSTEOARTHRITIS
C. Huesa y, L. McGavin y, A. Habgood z, J.C. Lockhart y, R. van ’t Hof x,
A.D. Rowan z, C. Goodyear k, I. MacInnes k, W.R. Ferrell k. yUniv. of the
West of Scotland, Glasgow, United Kingdom; zUniv. of Newcastle,
Newcastle, United Kingdom; xUniv. of Liverpool, Liverpool, United
Kingdom; kUniv. of Glasgow, Glasgow, United Kingdom
Purpose: Osteoarthritis (OA) is characterized by cartilage degradation
and osteophyte formation. Although cartilage degradation has been the
primary target for research on the pathogenesis of OA, there is
increasing recognition of the importance of bone changes in driving the
disease process. This study characterises the temporal proﬁle of bone
and cartilage changes in murine OA, speciﬁcally focusing on osteophyte
development and subchondral bone changes.
Methods: OA was induced in C57Bl/6 mice by destabilisation of the
medical meniscus (DMM), or sham operated, and bone was assessed by
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S370micro computed tomography (mCT, Skyscan 1172, 4.5 um resolution) of
the knee at 3, 7, 14, 28, 56, 84, 112 days (n 8 per group). Changes in
subchondral bone at 28 days post DMM (n ¼ 6) were measured sepa-
rating the subchondral plate from the subchondral tabecular structures.
Results: Osteophytes were identiﬁed in 70% of mice by day 7 post DMM
and in all mice by day 14. At day 7 most samples had 1 or 2 osteophytes,
with somehavingup to 4 osteophytes by day 14. Fromday 28onwards the
osteophytes fused and formed into one or two large osteophytes. Osteo-
phytes increased in size and bone content with time, plateauing by day
112. The trabeculae of the subchondral bone at day 28 showed a sig-
niﬁcant (p<0.03) decrease in trabecular number on the medial side of
both theDMMand shamoperatedmicewhen compared to the respective
contralateral leg. In the sham samples, the reduction of trabecular num-
ber translated to a signiﬁcant increase in trabecular space, whereas in the
DMMmice an increase in trabecular thickness occurred, eliminating the
increase in trabecular space. Although bone changes occurred within a
week of DMM induction, cartilage damage scores were not signiﬁcant
until day 56 (p<0.05), compared to earlier time points.
Conclusions:We herein charachterised differential bone changes in the
DMM murine model of OA: there was accelerated osteophyte devel-
opment within the ﬁrst week, whereas subchondral bone changes were
not evident until day 28. Interestingly sham operated animals showed
subchondral trabecular bone loss in the ipsilateral knee, highlighting
the need to use the contralateral knee as an internal control. The early
bone changes in this OA model signiﬁcantly preceded cartilage degra-
dation, consistent with altered bone biology being an important driver
of OA pathogenesis.Supported By Arthritis Research UK (20199).
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PPARDELTA PROMOTES THE PROGRESSION OF POST-TRAUMATIC
OSTEOARTHRITIS
A. Ratneswaran y, E. LeBlanc y, E. Walser y, I. Welch y, J.S. Mort z,x,
N. Borradaile y, F. Beier y,k. yWestern Univ., London, ON, Canada; zMcGill
Univ., Montreal, QC, Canada; x Shriner’s Hosp. for Children, Montreal, ON,
Canada; k Children’s Hlth.Res. Inst., London, ON, Canada
Background: Osteoarthritis (OA) is a degenerative joint disorder,
characterized by the breakdown of articular cartilage, subchondral bone
thickening, osteophyte formation and synovial inﬂammation. The
human burden of this disease inﬂuences both the independence and
quality of life of those afﬂicted. Currently, there are no pharmaceutical
treatments to slow, stop or reverse disease progression, resulting in
greatly reduced quality of life for OA patients and the need for joint
replacement surgeries in many cases. The lack of available treatments
for OA is partially due to our incomplete understanding of themolecular
mechanisms promoting disease initiation and progression. Recent
ﬁndings from our laboratory indicate that activation of the transcription
factor PPARdelta induces the expression of enzymes involved in pro-
teoglycan breakdown and can lead to cartilage degeneration in OA,
prompting us to speculate whether inhibition of PPARdelta, can protect
from cartilage breakdown in OA.
Purpose:We aimed to characterize the role of PPARdelta in OA through
in-vitro, ex-vivo, and in-vivo studies to determine whether it is a fea-
sible target for OA therapy.
Hypothesis: We hypothesize that inhibition of PPARdelta will slow the
progression of OA in animal models.
Methods: Primary mouse chondrocytes and cartilage explants were
treated with a pharmacological PPARdelta agonist (GW501516) to
evaluate changes in gene expression (qPCR), and histology (Safranin-O,
immunohistochemistry) consistent with OA development. In order to
examine the role of PPARdelta in-vivo, cartilage-speciﬁc knockout mice
and wild-type littermate controls were subjected to destabilization of
medial meniscus surgery (DMM) at 20 weeks of age. 8 weeks post-
surgery mice were compared through classical histological and bio-
chemical measures of OA progression including Safranin-O staining
with OARSI scoring, immunohistochemistry for cartilage matrix
breakdown products, and picrosirius red staining for collagen ﬁber
structure and orientation.
Results: In vitro, PPARdelta agonism (by GW501516) results in the
upregulation of expression of proteases implicated in cartilage degen-
eration (including MMPs, and ADAMTS genes). Activation of PPARdelta
also results in proteoglycan breakdown in the cartilage matrix of an
explant culture system. Mice with cartilage-speciﬁc deletion of PPAR-
delta do not demonstrate any abnormalities in skeletal growth or
development, but do show signiﬁcant chondroprotection in comparisonto wild-type littermate controls after surgical induction of OA. OARSI
scoring and immunohistochemistry conﬁrm strong protection of
mutant mice against cartilage matrix breakdown, and decreased
breakdown products in the cartilage of PPARdelta knockout mice.
Conclusion: This study provides strong evidence for catabolic roles of
endogenous PPARdelta in post-traumatic OA and suggests that phar-
macological inhibition of PPARdelta is a promising therapeutic strategy.
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DKK3 PREVENTS MATRIX LOSS INDUCED BY PRO-INFLAMMATORY
CYTOKINES IN HUMAN CARTILAGE EXPLANTS
S.M. Walzer, D. Bieder, B. Simon, R. Windhager, S. Toegel. Karl Chiari Lab
for Orthopaedic Biology, Dept. of Orthopaedics, Med. Univ. of Vienna,
Vienna, Australia
Purpose: Osteoarthritis (OA) is a prevalent disease with high socio-
economic impact characterized by loss of articular cartilage. High-
lighted by a number of genetic and cell biology studies, the interception
of cell signaling pathways imply an important mechanism in OA
development and pathogenesis. Dkk3 is a member of the Dickkopf
family of WNT antagonists which is recently recognised to be upregu-
lated in OA cartilage. In the pathogenesis of OA the WNT signaling
pathway plays a role but the function of DKK3 in inﬂammation of joints
is still poorly described. According to recent reports the activation of
WNT signaling leads to an upregulation of TNF-a. In our study we
investigated the response of DKK3 in human OA cartilage explants to
the pro-inﬂammatory cytokines IL1-b and TNF-a.
Methods: Osteochondral explants (5mm) were created from human
femoral condyles (n ¼ 3 donors) of OA patients. The explants were
treated in duplicates with 10ng/ml IL1-b, 10ng/ml TNF-a and 10ng/ml
IL1-b þ 10ng/ml TNF-a for 21 days. Controls were left untreated. The
medium was collected for GAG analysis. Safranin-O stained parafﬁn
sections (2.5 mm) of the explants were assessed by Mankin score. The
release of glycosaminoglycans (GAG) from explants into the culture
medium was measured based on 1,9-dimethylmethylene blue binding.
For immunolabeling, explants were incubatedwithmonoclonal antibody
Dkk3 to determine whether an elevation in Dkk3 presence was asso-
ciated with the activation of TNF-a and IL1-b. Parafﬁn embedded 2.5mm
sections were deparafﬁnized and blocked with 10% donkey serum for 30
min, and incubated incubated overnight at 4C with antibodies against
Dkk3 in a dilution of 1:100 in 0.05 M Tris Buffer. After washing the slides
with TBS, the secondary antibody alexa ﬂuor 488 was applied for one
hour at room temperature containing 10mM 40,6-diamidino-2-phenyl-
indole (DAPI) for nuclear staining. The slides were observed under a
confocal laser scanning microscope connected to a digital imaging sys-
tem. Negative controls leaving the primary antibody were prepared. To
identify the ability of Dkk3 to reduce the activity of pro-inﬂammatory
cytokines on matrix loss, we incubated cartilages explants with 10ng/ml
recombinant human Dkk3 prior to IL1-b and TNF-a.
Results: Osteochondral explants show an increased loss of GAG and
differences in the Mankin score by the use of pro-inﬂammatory cyto-
kines IL1-b and TNF-a. Immunoﬂuorescence analysis using Dkk3 anti-
body showed that TNF-a/IL1-b treatment (10ng/ml, 21 days) promoted
an increased occurrence of Dkk3þ chondrocytes mainly in the surface
and superﬁcial zone of the cartilage fraction of the explants and lacking
positive staining in the deep zone compared to control. Treatment with
Dkk3 prior to IL1-b and TNF-a indicate a decreased GAG loss in explants.
Conclusions: The regulation of signaling in the pathogenesis of OA is
subjected to several parameters which inﬂuence also the balance and
activity of pro-inﬂammatory factors in joints. The appearance of Dkk3
protein is increased in OA and modiﬁed by IL1-b and TNF-a. Our data
shows the protective role of Dkk3 by its ability to decrease the loss of
matrix in the presence of IL1-b and TNF-a.
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RELATIONSHIP BETWEEN SUBCHONDRAL BONE CYSTS, THE
SEVERITY OF KNEE OSTEOARTHRITIS, AND ALIGNMENTS OF
LOWER EXTREMITIES
N. Okazaki y, K. Chiba z, K. Kidera z, A. Yonekura z, M. Osaki z. yUniv. of
California, San Francisco, San francisco, CA, USA; zNagasaki Univ.,
Nagasaki, Japan
Purpose: To evaluate the characteristics of the subchondral bone cysts
(SBCs) in osteoarthritis (OA) of the knee.
